You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD8 T Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and

Not yet recruiting
  • Multiple Sclerosis
  • Progressive Multifocal Leukoencephalopathy
  • 89 Zr-Df-crefmirlimab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in

Recruiting
  • COVID-19
    • Baltimore, Maryland
    • +1 more
    Feb 2, 2023

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    CD8+ T-cell PET/CT Imaging in COVID-19 Patients

    Recruiting
    • Lymphopenia Due to COVID-19
    • +2 more
    • [89Zr]Df-IAB22M2C PET/CT scan
    • Nijmegen, Gelderland, Netherlands
      Radboud university medical center
    Jun 2, 2022

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Melanoma, Melanoma Stage III Trial in New York (diagnostic test, drug, procedure)

    Recruiting
    • Melanoma
    • Melanoma Stage III
    • PET Scan
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Jun 24, 2022

    Vitiligo Trial in Worcester (Metformin Hydrochloride)

    Not yet recruiting
    • Vitiligo
    • Metformin Hydrochloride
    • Worcester, Massachusetts
      UMass Chan Medical School
    Nov 6, 2022

    Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

    Not yet recruiting
    • Stage IIIB(N2) Non-small Cell Lung Cancer
    • +3 more
    • Pembrolizumab 200 mg IV infusion
    • Beijing, Beijing, China
      Peking University
    May 30, 2023

    Alterations in CD8aß and CD8aa T Cell Levels in Rheumatoid

    Not yet recruiting
    • Rheumatoid Arthritis
    • flow cytometry
    • (no location specified)
    Apr 12, 2023

    EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma Trial in Korea,

    Recruiting
    • EBV Associated Extranodal NK/T-cell Lymphoma
    • EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
    • EBViNT Cell
    • Seoul, Gangnam-gu, Korea, Republic of
    • +7 more
    Jul 7, 2022

    Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Metastatic Colorectal Adenocarcinoma
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 12, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

    Recruiting
    • HNSCC
    • +5 more
    • DP CD8 TIL
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 5, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    NSCLC, Small Cell Lung Cancer, Pancreas Cancer Trial in Shanghai (Infusion of iNKT cells and CD8+T cells)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Infusion of iNKT cells and CD8+T cells
    • Shanghai, Shanghai, China
      Shanghai Public Health Clinical Center
    May 6, 2022

    Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

    Not yet recruiting
    • Glioblastoma
    • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
    • Gainesville, Florida
      University of Florida Health
    Jul 29, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • +6 more
    • Axicabtagene Ciloleucel
    • +10 more
    • (no location specified)
    Jan 13, 2023

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent Grade 3b Follicular Lymphoma Trial in Seattle

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 30, 2022

    LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

    Recruiting
    • LGLL - Large Granular Lymphocytic Leukemia
    • +13 more
    • Duarte, California
    • +9 more
    Aug 9, 2022

    Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) Trial in Milwaukee (8/12-Day

    Recruiting
    • Non Hodgkin Lymphoma (NHL)
    • +6 more
    • 8/12-Day Production of Car-T Cells
    • +2 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin and Froedtert Hospital
    Jul 1, 2022

    Different Susceptibility to SARS CoV-2 Infection Among Health

    Completed
    • Health Care Worker Patient Transmission
    • +3 more
    • Susceptibility to infection
    • Madrid, Spain
      Hospital Ramon y Cajal
    Oct 23, 2021

    Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

    Not yet recruiting
    • Oropharyngeal Cancer
    • +10 more
    • (no location specified)
    Dec 14, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in

    Suspended
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 23, 2022

    Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Transformed Chronic

    Not yet recruiting
    • Recurrent Transformed Chronic Lymphocytic Leukemia
    • +7 more
    • Biospecimen Collection
    • +9 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 15, 2023